F8631e88 7755 4b29 848c 7ef657463803 01
Oxybutynin Tablet, Film Coated, Extended Release
Product Images NDC 68382-255
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Oxybutynin (NDC 68382-255). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
F8631e88 7755 4b29 848c 7ef657463803 02
F8631e88 7755 4b29 848c 7ef657463803 03
F8631e88 7755 4b29 848c 7ef657463803 04
This text appears to be a medication label that includes the name of the drug "Oxybutynin chloride" and its form as "extended-release tablets". The other text may indicate a comparison between this medication and a placebo, which is often used in clinical trials to test the effectiveness of a drug. The numbers "-40", "20", and "40" may represent some sort of scale or measurement, but without more context it is unclear what they refer to.*
F8631e88 7755 4b29 848c 7ef657463803 05
This appears to be a product label for Oxybutynin chloride extended-release tablets. Oxybutynin is a medication used to treat symptoms of an overactive bladder. The numbers on the label are unclear and may not be relevant to the description of the product.*
F8631e88 7755 4b29 848c 7ef657463803 06
This text seems to be a list of medications. The first two lines indicate the name of the drug "oxybutynin chloride" and the third line suggests that the drug is available in extended-release tablet form. However, the last three lines are unclear and do not provide any useful information.*
F8631e88 7755 4b29 848c 7ef657463803 07
The text describes a medication with the NDC code 68382-255-01, also known as Oxybutynin Chloride, which is an extended-release medication. It comes in the form of film-coated tablets and should not be chewed or crushed before ingestion. The medication should be stored at a controlled room temperature between 20-25°C to protect it from moisture and humidity. The package insert provides complete prescribing information, and the usual dosage is stated as once daily. The medication is distributed by Zydus Pharmaceuticals in the United States, and the manufacturer is Cadila Healthcare Limited in India. The text also includes a warning to keep the medication out of the reach of children.*
F8631e88 7755 4b29 848c 7ef657463803 08
Oxybutynin Chloride Simmsamreasms, Extended-Release Tablets, USP 558 ot o T. It is recommended to protect the drug from moisture and humidity, dispense in a tight container, and keep it out of children's reach. The tablets should be swallowed whole without chewing, dividing or crushing. The manufacturer is Zydus Healthcare Ltd from Ahmedabad, India, and it is distributed by Zydus Pharmaceuticals (USA) Inc. Available in 100 tablets and requires a prescription.*
F8631e88 7755 4b29 848c 7ef657463803 09
This is a description of a medication called Oxybutynin Chloride Saiemsamreasas. The medication comes in the form of extended-release tablets and has instructions to protect the medication from moisture and humidity. It is recommended to store the medication in a tight container and to keep it out of reach of children. The medication is manufactured by Cantla Healthcare Ltd. in Ahmedabad, India and is distributed by Zydus Pharmaceuticals (USA). The package contains 100 tablets.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
